sodium hyaluronate lipoate + sodium hyaluronate lipoate formate Gel - 8 ml tube
Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Oral care
Product description
medical device line specifically designed for the management of oral mucosal lesions
including aphthae, and irritations of the oral cavity. They are based on the patented
Technology, which modifies sodium hyaluronate with lipoic and formic acid residues, creating two novel deri-
vatives: Sodium Hyaluronate Lipoate (SHL) and Sodium Hyaluronate Lipoate Formate (SHLF). This technology
forms a biocompatible, long-lasting protective matrix that adheres to the mucosa, preserves hydration, and
supports tissue recovery.
Comments
Main actions
• forms a persistent protective film
• maintains mucosal hydration
• provides mechanical protection against external agents
• supports physiological repair of the oral epithelium
• reduces irritation caused by food, braces or prostheses
main features:
patented hyaluromimethic® technology
in vitro test: barrier effect up to 8 hours
formation of a stable 3d bioadhesive network
high biocompatibility and safety profile
Manufacturer #39377
European CDMO group formed in 2025 through strategic alliance of companies with combined decades of manufacturing expertise across pharmaceutical, cosmetic, and medical device sectors. Operates 7 EU-GMP certified facilities across 40,000 m² producing Rx and OTC solids, liquids, semi-solids, and injectables. Serves pharmaceutical, cosmetics, and nutraceutical clients across Europe and international markets.